eMedicine Specialties > Dermatology > Benign Neoplasms

Digital Mucous Cyst: Treatment & Medication

Author: Murad Alam, MD, Associate Professor of Dermatology, Otolaryngology, and Surgery; Chief, Section of Cutaneous and Aesthetic Surgery, Department of Dermatology, Northwestern University; Director, Mohs Micrographic Surgery, Northwestern Memorial Hospital
Coauthor(s): David Bickers, MD, Chairman, Carl Truman Nelson Professor, Department of Dermatology, New York Presbyterian Hospital, Columbia University; Natalie Ann Kim,, Northwestern University, The Feinberg School of Medicine
Contributor Information and Disclosures

Updated: Aug 6, 2009

Treatment

Medical Care

Medical care for digital mucous cysts (DMCs) includes the following:

  • Soaks
  • Local heat
  • Massage
  • Occlusive treatment with topical steroids and Cordran tape
  • Home remedies - Salves, poultices, and plasters
  • Application of heparin cream
  • Silver nitrate
  • Chemical cauterization with phenol
  • Digital compression, if the cyst is soft and located over a bony prominence
  • Striking with a large book (potential for unintended trauma)
  • X-ray therapy and radium irradiation (of historical interest only)

Surgical Care

  • The most conservative surgical intervention entails multiple episodes of needling the cyst with a wide-bore needle until resolution is achieved. An appropriately trained patient may continue the repeated drainage and scarification required by this method at home.6
  • Another technique is cyst aspiration with a large-bore needle, followed by instillation of corticosteroids (triamcinolone, hydrocortisone, betamethasone) with or without lidocaine. Some practitioners prefer to inject proteolytic agents, such as hyaluronidase, in lieu of steroids, but this may be potentially more risky given the communication of the cyst with the joint.7
  • Cryosurgery has been used to treat digital mucous cysts. Carbon dioxide snow, cryoprobes, and the intermittent spray technique have been used.8
  • Sclerotherapy was considered a quick and effective method of treatment.9 Among the sclerosants infused were Morton fluid, iodine and carbolic acid, sodium morrhuate, ethanolamine, sodium tetradecyl, and polidocanol. Some consider sclerotherapy a dangerous approach because of the potential for extravasation of the chemical into the joint or tendon sheath. However, a 2008 study reported effective treatment of digital mucous cysts with percutaneous sclerotherapy using polidocanol.10
  • Curettage of the cyst may be attempted, and this may or may not be combined with electrodesiccation. Caution should be exercised to reduce the risk of scar.
  • High-intensity light sources recently have demonstrated at least short-term success in the management of digital mucous cysts. Cysts have been vaporized with the carbon dioxide laser and treated with infrared contact coagulation.11,12
  • Dermatologic and plastic surgeons have practiced cold-steel surgical excision of digital mucous cysts for several decades. This procedure ranges from simple excision of the cyst to wide, radical excision with possible graft13 or flap reconstruction. Flaps used for reconstruction have historically been rotation flaps,14 but rhomboid flaps15 have been used safely and reliably and may be easier to apply in selected situations.
  • Another approach is marsupialization, or excision of the whole proximal nail fold, with subsequent healing by secondary intention.
  • In recent years, excision and debridement of joint osteophytes has been recognized as a necessary adjunct to reduce the risk of recurrence. Some hand surgeons believe that excision and debridement of the marginal osteophyte without removal of the cyst itself may be the best intervention. This results in less postoperative impairment in joint motion and fewer nail deformities since cyst dissection around the germinal matrix potentially may injure the underlying matrix and cause scarring. In general, more aggressive dissection leads to fewer recurrences and more nail deformities.
  • More recently, nail surgeons have attempted to treat recurrent or refractory cysts by repairing the causative leak of joint fluid in such lesions.16 Methylene blue dye is first injected into the distal interphalangeal (DIP) joint. Then, a skin flap is raised around the cyst to find the area of dye-filled communication between the joint space and the cyst. This communication is then sutured shut and the flap is dropped back into place without tissue resection.
  • Overall, significant disagreement exists in the literature regarding optimal treatment approaches.
    • Dermatologists tend to favor more conservative treatments such as multiple needling or aspiration followed by steroid injection; they have reported high success rates and relatively low risks of recurrence.
    • Hand surgeons have noted success and rare recurrence with osteophyte excision and debridement, but their patient population is comprised of those who fail other treatments. All of the literature is biased toward the minority of patients who seek medical care for their digital mucous cysts. Asymptomatic cysts and spontaneous regression appear to be common, with several series suggesting that the likelihood of the latter may approximate 50%.
    • Additionally, as the aggressiveness of interventions to treat digital mucous cysts increases, the associated costs also increase. Conservative treatments offer the prospect of low cost, low morbidity, and the elimination of disability and time loss related to recovery from surgery.
    • Consequently, a reasonable treatment plan for symptomatic digital mucous cysts may entail initial needling or aspiration and injection; if these modalities fail repeatedly, patients may be referred to a hand surgeon for more radical surgery but must be forewarned of the increased risk of complications and offered the option of simply deferring treatment for this essentially benign entity.

Consultations

  • Dermatologist
  • Dermatologic surgeon
  • Hand surgeon

Medication

Many medications have been used for the treatment of digital mucous cysts. At present, injectable corticosteroids commonly are used, and the most frequently administered agent is triamcinolone acetonide. If a ruptured or partially treated cyst becomes infected, antibiotic therapy with a penicillin or cephalosporin (eg, cephalexin) may be indicated. Silver nitrate and heparin cream also have been used. Currently, no standard doses exist for heparin or for silver nitrate.

Corticosteroids

May result in involution or shrinkage of the cyst. Have anti-inflammatory properties and cause profound and varied metabolic effects. In addition, these agents modify the body's immune response to diverse stimuli.


Triamcinolone (Aristocort)

Used in dermatology for its anti-inflammatory and antipruritic properties. Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. Dilute with isotonic sodium chloride solution to a concentration of 2.5-5 mg/mL prior to injection. Total quantity injected may be 0.10 mL or less and a 30-gauge needle is used.

Adult

2.5-40 mg (10 mg/mL or 40 mg/mL formulations; intra-articular, intradermal); repeat prn

Pediatric

Discuss with pediatrician prior to use; dilution of 2.5 mg/mL may be appropriate

Coadministration with barbiturates, phenytoin, and rifampin decreases effects
Coadministration with estrogens may decrease clearance; when used with digoxin, digitalis toxicity secondary to hypokalemia may increase; phenobarbital, phenytoin, and rifampin may increase the metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics; coadministration with ritonavir may significantly increase serum concentrations of prednisone; concomitant therapy with montelukast may result in severe peripheral edema; clarithromycin may increase risk of psychotic symptoms
Postmarketing surveillance reports indicate that risk of tendon rupture may be increased in patients receiving concomitant fluoroquinolones and corticosteroids, especially elderly patients; administration of asparaginase concurrently with or before steroid therapy may result in increased toxicity

Documented hypersensitivity; fungal, viral, and bacterial skin infections

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Multiple complications (eg, severe infections, hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression) may occur; abrupt discontinuation of glucocorticoids may cause adrenal crisis; may cause cutaneous atrophy and localized depigmentation; if local irritation develops, discontinue use

Anti-infectives

Treat skin and skin structure infections caused by susceptible organisms.


Cephalexin (Keflex, Biocef)

First-generation cephalosporin arrests bacterial growth by inhibiting bacterial cell wall synthesis. Bactericidal activity against rapidly growing organisms. Primary activity against skin flora; used for skin infections or prophylaxis in minor procedures.

Adult

250-500 mg PO q6h for 10-14 d

Pediatric

25-50 mg/kg PO divided bid/qid

Renal excretion of cephalexin is inhibited by probenecid; coadministration with aminoglycosides increase nephrotoxic potential

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Caution in history of penicillin allergy; risk of pseudomembranous colitis; prolonged use may result in overgrowth of resistant organisms; commonly seen GI effects include severe diarrhea, nausea, vomiting, vaginitis, and vaginal moniliasis; less common to rare effects are neutropenia, eosinophilia, immune hemolytic anemia, neurotoxicity, psychosis, nephrotoxicity, and hepatotoxicity; dermatologic effects may include urticaria, dermatitis, as well as pemphigus vulgaris, Stevens-Johnson syndrome, and toxic epidermal necrolysis; adjust dose in renal impairment; may cause false-positive test for glucose in the urine

More on Digital Mucous Cyst

Overview: Digital Mucous Cyst
Differential Diagnoses & Workup: Digital Mucous Cyst
Treatment & Medication: Digital Mucous Cyst
Follow-up: Digital Mucous Cyst
Multimedia: Digital Mucous Cyst
References

References

  1. Lin YC, Wu YH, Scher RK. Nail changes and association of osteoarthritis in digital myxoid cyst. Dermatol Surg. Mar 2008;34(3):364-9. [Medline].

  2. Kivanc-Altunay I, Kumbasar E, Gokdemir G, Koslu A, Tekkesin M, Basak T. Unusual localization of multiple myxoid (mucous) cysts of toes. Dermatol Online J. Jul 15 2004;10(1):23. [Medline].

  3. Drape JL, Idy-Peretti I, Goettmann S, et al. MR imaging of digital mucoid cysts. Radiology. Aug 1996;200(2):531-6. [Medline].

  4. Daffner RH, Whitfield PW. Recurrent ganglion cyst: the value of preoperative ganglionography. AJR Am J Roentgenol. Aug 1977;129(2):345-6. [Medline].

  5. Dodd LG, Layfield LJ. Fine-needle aspiration cytology of ganglion cysts. Diagn Cytopathol. Dec 1996;15(5):377-81. [Medline].

  6. Epstein E. A simple technique for managing digital mucous cysts. Arch Dermatol. Nov 1979;115(11):1315-6. [Medline].

  7. Epstein E. Steroid injection of myxoid finger cysts. JAMA. 1965;194:98-99.

  8. Bardach HG. Managing digital mucoid cysts by cryosurgery with liquid nitrogen: preliminary report. J Dermatol Surg Oncol. Jun 1983;9(6):455-8. [Medline].

  9. Audebert C. Treatment of mucoid cysts of fingers and toes by injection of sclerosant. Dermatol Clin. Jan 1989;7(1):179-81. [Medline].

  10. Córdoba S, Romero A, Hernández-Nuñez A, Borbujo JM. Treatment of digital mucous cysts with percutaneous sclerotherapy using polidocanol. Dermatol Surg. Oct 2008;34(10):1387-8; discussion 1388. [Medline].

  11. Huerter CJ, Wheeland RG, Bailin PL, Ratz JL. Treatment of digital myxoid cysts with carbon dioxide laser vaporization. J Dermatol Surg Oncol. Jul 1987;13(7):723-7. [Medline].

  12. Kemmett D, Colver GB. Myxoid cysts treated by infra-red coagulation. Clin Exp Dermatol. Mar 1994;19(2):118-20. [Medline].

  13. Jamnadas-Khoda B, Agarwal R, Harper R, Page RE. Use of Wolfe Graft for the Treatment of Mucous Cysts. J Hand Surg Eur Vol. Apr 24 2009;[Medline].

  14. Blume PA, Moore JC, Novicki DC. Digital mucoid cyst excision by using the bilobed flap technique and arthroplastic resection. J Foot Ankle Surg. Jan-Feb 2005;44(1):44-8. [Medline].

  15. Imran D, Koukkou C, Bainbridge LC. The rhomboid flap: a simple technique to cover the skin defect produced by excision of a mucous cyst of a digit. J Bone Joint Surg Br. Aug 2003;85(6):860-2. [Medline].

  16. de Berker D, Lawrence C. Ganglion of the distal interphalangeal joint (myxoid cyst): therapy by identification and repair of the leak of joint fluid. Arch Dermatol. May 2001;137(5):607-10. [Medline].

  17. Armijo M. Mucoid cysts of the fingers. Differential diagnosis, ultrastructure, and surgical treatment. J Dermatol Surg Oncol. Apr 1981;7(4):317-22. [Medline].

  18. de Berker D, Goettman S, Baran R. Subungual myxoid cysts: clinical manifestations and response to therapy. J Am Acad Dermatol. Mar 2002;46(3):394-8. [Medline].

  19. Fritz GR, Stern PJ, Dickey M. Complications following mucous cyst excision. J Hand Surg Br. Apr 1997;22(2):222-5. [Medline].

  20. Herndon JH, Myers SR, Akelman E. Advanced surgery. In: Scher RK, Daniel CR, eds. Nails: Therapy Diagnosis, Surgery. 2nd ed. Philadelphia: WB Saunders Co; 1997:350-362.

  21. Kasdan ML, Stallings SP, Leis VM, Wolens D. Outcome of surgically treated mucous cysts of the hand. J Hand Surg Am. May 1994;19(3):504-7. [Medline].

  22. Loder RT, Robinson JH, Jackson WT, Allen DJ. A surface ultrastructure study of ganglia and digital mucous cysts. J Hand Surg Am. Sep 1988;13(5):758-62. [Medline].

  23. Nishimura M, Kohda H, Takazono I, Tanaka Y. Chemical components of jelly-like matrix in digital mucous cyst. Clin Exp Dermatol. Mar 1985;10(2):116-20. [Medline].

  24. Norton LA. Tumors. In: Scher RK, Daniel CR, eds. Nails: Therapy, Diagnosis, Surgery. 2nd ed. Philadelphia: WB Saunders Co; 1997:262-275.

  25. Read JW, Conolly WB, Lanzetta M, Spielman S, Snodgrass D, Korber JS. Diagnostic ultrasound of the hand and wrist. J Hand Surg Am. Nov 1996;21(6):1004-10. [Medline].

  26. Salasche SJ. Myxoid cysts of the proximal nail fold: a surgical approach. J Dermatol Surg Oncol. Jan 1984;10(1):35-9. [Medline].

  27. Sonnex TS. Digital myxoid cysts: a review. Cutis. Feb 1986;37(2):89-94. [Medline].

  28. Zuber TJ. Office management of digital mucous cysts. Am Fam Physician. Dec 15 2001;64(12):1987-90. [Medline].

Further Reading

Keywords

digital mucous cyst, digital mucous cysts, DMC, cystomata, myxomatous cutaneous cysts, myxomatous degenerative cysts, periarticular fibromas, synovial lesions of the skin, periungual ganglions, mucous cysts, myxoid cysts, synovial cysts, dorsal cysts, nail cysts, cystic nodules, digital mucoid cysts, digital myxoid cysts, digital mucinous pseudocysts, focal mucinosis, periungual ganglia

Contributor Information and Disclosures

Author

Murad Alam, MD, Associate Professor of Dermatology, Otolaryngology, and Surgery; Chief, Section of Cutaneous and Aesthetic Surgery, Department of Dermatology, Northwestern University; Director, Mohs Micrographic Surgery, Northwestern Memorial Hospital
Murad Alam, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American Medical Association, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, American Society of Cosmetic Dermatology and Aesthetic Surgery, Phi Beta Kappa, Society for Investigative Dermatology, and Women's Dermatologic Society
Disclosure: Nothing to disclose.

Coauthor(s)

David Bickers, MD, Chairman, Carl Truman Nelson Professor, Department of Dermatology, New York Presbyterian Hospital, Columbia University
David Bickers, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Dermatological Association, American Society for Clinical Investigation, American Society for Pharmacology and Experimental Therapeutics, Association of American Physicians, Central Society for Clinical Research, New York Academy of Sciences, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Natalie Ann Kim,, Northwestern University, The Feinberg School of Medicine
Disclosure: Nothing to disclose.

Medical Editor

Richard K Scher, MD, Professor of Dermatology, University of North Carolina
Richard K Scher, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Cryosurgery, American College of Physicians, American Dermatological Association, American Geriatrics Society, American Medical Association, Association of Military Surgeons of the US, International Society for Dermatologic Surgery, New York Academy of Sciences, Noah Worcester Dermatological Society, Rhode Island Medical Society, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Mary Farley, MD, Dermatologic Surgeon/Mohs Surgeon, Anne Arundel Surgery Center
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.